Skip to main content

Pharmacopeial Forum Table of Contents

View the current Pharmacopeial Forum (PF) Table of Contents. Forolder PF tables of contents, visit our archive.

Select from the below links to access PF content. A free resource, PF visitors mustcreate a user name and password.

PF 47(3) Table of Contents Publish date: [May 3, 2021]

In-Process Revision

In-Process Revision Introduction

General Test and Assay Chapter

<771> Ophthalmic Products - Quality Tests (USPNF 2022 ISSUE 3)

<781> Optical Rotation (USPNF 2022 ISSUE 3)

<787> Subvisible Particulate Matter in Therapeutic Protein Injections (USPNF 2022 ISSUE 3)

<789> Subvisible Particulate Matter in Ophthalmic Solutions (USPNF 2022 ISSUE 3)

<831> Refractive Index (USPNF 2022 ISSUE 3)

Reagents, Indicators, and Solutions

Reagent Specifications

Cesium Carbonate [NEW] (USPNF 2022 ISSUE 3)

Deuterated Acetone [NEW] (USPNF 2022 ISSUE 3)

Deuterochloroform (USPNF 2022 ISSUE 3)

Potassium Hexafluorophosphate [NEW] (USPNF 2022 ISSUE 3)

Triphenyl Phosphate [NEW] (USPNF 2022 ISSUE 3)

Volumetric Solutions

0.1 N Ferric Ammonium Sulfate VS (USPNF 2022 ISSUE 3)

0.1 N Sulfuric Acid VS [NEW] (USPNF 2022 ISSUE 3)

Chromatographic Columns

L127 [NEW] (USPNF 2022 ISSUE 3)

Description and Solubility

Description and Solubility (USPNF 2022 ISSUE 3)

USP Monographs

Abacavir, Lamivudine, and Zidovudine Tablets (USPNF 2022 ISSUE 3)

Amantadine Hydrochloride Tablets [NEW] (USPNF 2022 ISSUE 3)

Calcium Ascorbate (USPNF 2022 ISSUE 3)

Codeine (USPNF 2022 ISSUE 3)

Diphenhydramine Hydrochloride Oral Powder (USPNF 2022 ISSUE 3)

Enzacamene (USPNF 2022 ISSUE 3)

Esomeprazole Sodium [NEW] (USPNF 2022 ISSUE 3)

Esomeprazole Sodium for Injection [NEW] (USPNF 2022 ISSUE 3)

Ethionamide (USPNF 2022 ISSUE 3)

Etravirine [NEW] (USPNF 2022 ISSUE 3)

Etravirine Tablets [NEW] (USPNF 2022 ISSUE 3)

Fluorouracil Injection (USPNF 2022 ISSUE 3)

Fluticasone Propionate (USPNF 2022 ISSUE 3)

Diluted Isosorbide Mononitrate (USPNF 2022 ISSUE 3)

Omega-3-Acid Ethyl Esters (USPNF 2022 ISSUE 3)

Oxycodone Hydrochloride Tablets (USPNF 2022 ISSUE 3)

Polyethylene Glycol 3350 for Oral Solution [NEW] (USPNF 2022 ISSUE 3)

Prasugrel Hydrochloride (USPNF 2022 ISSUE 3)

Propranolol Hydrochloride Injection (USPNF 2022 ISSUE 3)

Saquinavir Mesylate (USPNF 2022 ISSUE 3)

Trichlormethiazide (USPNF 2022 ISSUE 3)

Valacyclovir Hydrochloride (USPNF 2022 ISSUE 3)

Valganciclovir for Oral Solution [NEW] (USPNF 2022 ISSUE 3)

Dietary Supplement Monographs

Bael Tree Fruit (USPNF 2022 ISSUE 3)

Bael Tree Fruit Dry Extract (USPNF 2022 ISSUE 3)

Bael Tree Fruit Powder (USPNF 2022 ISSUE 3)

Cranberry Fruit Juice Dry Extract Capsules [NEW] (USPNF 2022 ISSUE 3)

Dong Quai Root [NEW] (USPNF 2022 ISSUE 3)

Dong Quai Root Powder [NEW] (USPNF 2022 ISSUE 3)

Fish Oil Omega-3 Acid Ethyl Esters Concentrate (USPNF 2022 ISSUE 3)

Fish Oil Containing Omega-3 Acids (USPNF 2022 ISSUE 3)

Fish Oil Containing Omega-3 Acids Capsules (USPNF 2022 ISSUE 3)

Fish Oil Containing Omega-3 Acids Delayed-Release Capsules (USPNF 2022 ISSUE 3)

L-alpha-Glycerylphosphorylcholine (USPNF 2022 ISSUE 3)

Krill Oil (USPNF 2022 ISSUE 3)

Krill Oil Capsules (USPNF 2022 ISSUE 3)

Krill Oil Delayed-Release Capsules (USPNF 2022 ISSUE 3)

Lactiplantibacillus plantarum [NEW] (USPNF 2022 ISSUE 3)

Ligilactobacillus salivarius [NEW] (USPNF 2022 ISSUE 3)

Conjugated Linoleic Acids-Free Fatty Acids (USPNF 2022 ISSUE 3)

Omega-3 Acid Triglycerides (USPNF 2022 ISSUE 3)

Omega-3 Free Fatty Acids (USPNF 2022 ISSUE 3)

Streptococcus thermophilus [NEW] (USPNF 2022 ISSUE 3)

Stage 2 Harmonization

Stage 2 Harmonization Introduction

<788> Particulate Matter in Injections (USPNF 2022 ISSUE 3)

Stimuli to The Revision Process

Filling the Pharmacopeial Gaps of Visual Inspection: Toward Standardization and Consistency of Visible Particle Testing [NEW]